Found: 19
Select item for more details and to access through your institution.
Transmission and Clinical Features of Enterovirus 71 Infections in Household Contacts in Taiwan.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 2, p. 222, doi. 10.1001/jama.291.2.222
- By:
- Publication type:
- Article
Pre‐operative chemoradiotherapy with oral tegafur‐uracil and leucovorin for rectal cancer.
- Published in:
- Journal of Surgical Oncology, 2005, v. 89, n. 4, p. 256, doi. 10.1002/jso.20168
- By:
- Publication type:
- Article
A New Tumor Suppressor DnaJ-like Heat Shock Protein, HLJ1, and Survival of Patients With Non-Small-Cell Lung Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 12, p. 825, doi. 10.1093/jnci/djj229
- By:
- Publication type:
- Article
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183680
- By:
- Publication type:
- Article
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.
- Published in:
- Nature Cell Biology, 2009, v. 11, n. 6, p. 694, doi. 10.1038/ncb1875
- By:
- Publication type:
- Article
The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 335, doi. 10.1007/s10928-024-09913-y
- By:
- Publication type:
- Article
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 4, p. 355, doi. 10.1245/ASO.2003.10.002
- By:
- Publication type:
- Article
Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 4, p. 277, doi. 10.1111/j.1440-1746.1997.tb00421.x
- By:
- Publication type:
- Article
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4670, doi. 10.1111/bcp.14886
- By:
- Publication type:
- Article
A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignancies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 867, doi. 10.1002/psp4.12799
- By:
- Publication type:
- Article
Author reply.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 3, p. 567, doi. 10.1002/(SICI)1097-0142(19960801)78:3<567::AID-CNCR28>3.0.CO;2-W
- By:
- Publication type:
- Article
Phase II study of flutamide in the treatment of hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 4, p. 635, doi. 10.1002/(SICI)1097-0142(19960215)77:4<635::AID-CNCR8>3.0.CO;2-F
- By:
- Publication type:
- Article
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 5, p. 602, doi. 10.3390/pharmaceutics16050602
- By:
- Publication type:
- Article
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102159
- By:
- Publication type:
- Article